New biomarkers for clinical management of hepatitis C virus infected patients

doi:10.5495/wjcid.v5.i4.59

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (12455)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series.

Item

Count

PDF

792

WORD

506

HTML

6119

Figures (1-1)

335

Sum=7752

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

616

Download

1569

Sum=2185

Publishing Process of This Article

Item

Count

Browse

1037

Download

1481

Sum=2518

Nov 25, 2015 (publication date) through Nov 12, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Clinical Infectious Diseases

ISSN

2220-3176

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Clin Infect Dis. Nov 25, 2015; 5(4): 59-66
Published online Nov 25, 2015. doi: 10.5495/wjcid.v5.i4.59

Open in New Tab Full Size Figure Download Figure

Figure 1 Current and newly proposed biomarkers of liver disease progression and hepatocellular carcinoma development. AFP: α-fetoprotein; AFP-L3: Lens culinaris agglutinin A (LCA) - reactive fraction of α-AFP; DCP: Des-γ-carboxyprothrombin; h-TERTmRNA: Human telomerase reverse trascriptase mRNA; WFA + M2BP: Wisteria floribunda agglutinin-positive human Mac-2-binding protein; SCCA-IgM: Squamous cell carcinoma antigen-immunoglobulin M; HCC: Hepatocellular carcinoma.

Citation: Biasiolo A, Martini A, Pontisso P. New biomarkers for clinical management of hepatitis C virus infected patients. World J Clin Infect Dis 2015; 5(4): 59-66
URL: https://www.wjgnet.com/2220-3176/full/v5/i4/59.htm
DOI: https://dx.doi.org/10.5495/wjcid.v5.i4.59